Abstract
Recurrence rate of hepatocellular carcinoma remains quite high even after surgery, and no postoperative therapies have been definitively shown to prevent hepatocellular carcinoma recurrence. A previous study showed that therapy with nucleos(t)ide analogues given to such patients after surgery significantly improved survival. However, many questions still exist about the usage of nucleos(t)ide analogues for patients with hepatocellular carcinoma after surgery.
| Original language | English |
|---|---|
| Pages (from-to) | 605-606 |
| Number of pages | 2 |
| Journal | World Journal of Hepatology |
| Volume | 8 |
| Issue number | 13 |
| DOIs | |
| State | Published - 1 May 2016 |
| Externally published | Yes |
Keywords
- Antiviral therapy
- Hepatitis B virus
- Hepatocellular carcinoma
- Unanswered question